We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Urinary Eosinophils Commonly Found After Bladder Surgery

By LabMedica International staff writers
Posted on 23 Nov 2011
Urine samples are examined for the presence of eosinophils, which are used to screen for acute interstitial nephritis (AIN). More...


Patients with urinary diversion surgeries such as ileal conduit surgery, frequently have an unusually high number of urinary eosinophils, a specific kind of white cell.

At the Mayo Clinic (Rochester, MN, USA) technologists examined urine samples from three cohorts with 20 patients in each group. In the first group, urinalysis samples were with a “stoma” source indicating a previous ileal conduit surgery; in the second group the urine samples had been clinically submitted for eosinophil quantification; and for the third cohort, randomly selected urinalysis samples was performed where there was with a minimum of 1-3 leucocytes per high-powered field. Urinary eosinophils were quantified after Hansel staining as the mean of independent counts by four technologists who did not know the source. Hansel stain is used to detect eosinophils in urine or other body fluids, the eosinophils staining red against a background of blue.

In the stoma group, eosinophils composed an average 19% of the urinary white cells even though none had a clinical suspicion of AIN. In contrast, only 3.5% and 4.6% of the urinary leucocytes were eosinophils among patients with clinically ordered eosinophiluria testing and in a random sample of patients with pyuria, respectively. Importantly, 18 out of 20 (90%) of the stoma patients had greater than 5% eosinophils, meeting the criterion for a positive test.

The authors concluded that patients with a previous ileal conduit surgery have markedly elevated urinary eosinophils, far in excess of typical patients with pyuria or those with clinically ordered eosinophiluria testing. Therefore, urinary eosinophils are not a useful screen for AIN in patients after ileal conduit surgery. Acute interstitial nephritis is an immunologic adverse reaction to certain drugs, often sulfonamide or methicillin. Acute renal failure, fever, rash, and proteinuria are characteristic of this condition. The study was published in the November 2011 edition of the journal Clinical Chemistry and Laboratory Medicine.

Related Links:

Mayo Clinic




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
All-in-One Molecular System
AIO M160
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Signatera uses ctDNA analysis to identify residual tumor-derived genetic material after definitive treatment (image credit: Adobe Stock)

Blood-Based MRD Test Predicts Recurrence Risk After Lung Cancer Surgery

Assessing recurrence risk after surgery for early-stage non-small cell lung cancer remains challenging, complicating adjuvant therapy and surveillance decisions. Blood-based molecular residual disease... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

Type 1 diabetes (T1D) affects more than 9 million people worldwide, including 1.8 million children and adolescents, and often begins years before symptoms appear. Early identification of children who are... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.